Drinkable immediate release tablet made with direct compression of memantine or neramexane

Details for Australian Patent Application No. 2005328701 (hide)

International Classifications

Event Publications

21 December 2006 PCT application entered the National Phase

PCT publication WO2006/096194 Priority application(s): WO2006/096194

13 August 2009 Application Accepted

Published as AU-B-2005328701

24 September 2009 Amendment Made

The nature of the amendment is: Amend the name of the coinventors from Hauptmeier, Bernbhard; Dedihiya, Mahendra G. to Hauptmeier, Bernhard; Dedhiya, Mahendra G. 2006

8 October 2009 Application for Amendment

The nature of the amendment is: Amend the name of the co-inventor from Janjikhel, Ragiv; Hauptmeier, Bernbhard; Dedihiya, Mahendra G. to Janjikhel, Rajiv; Hauptmeier, Bernhard; Dedhiya, Mahendra G.. Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000 2006

8 October 2009 Corrigenda

Amendments - Amendments Made Under the name Merz Pharma GmbH & Co. KgaA delete all reference to application No. 2005328701

21 January 2010 Amendment Made

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.